A call to action: Global Blood Therapeutics on tackling orphan disease

Pathfinders in Biopharma - A podcast by RBC Capital Markets

Categories:

Business

What does it take to tackle the most perplexing orphan diseases? Ted W. Love, M.D., President and CEO, Global Blood Therapeutics (GBT), speaks with RBC Capital Markets’ Senior Biotechnology Analyst Gregory Renza, M.D., about having a mission and the drive to succeed on this episode of Pathfinders.